Investigation of the Use of Nesiritide in Transplant-Eligible Management of Congestive Heart Failure-TMAC.

Trial Profile

Investigation of the Use of Nesiritide in Transplant-Eligible Management of Congestive Heart Failure-TMAC.

Discontinued
Phase of Trial: Phase II

Latest Information Update: 10 Dec 2014

At a glance

  • Drugs Nesiritide (Primary) ; Dobutamine; Milrinone
  • Indications Heart failure
  • Focus Therapeutic Use
  • Acronyms TMAC
  • Sponsors Scios
  • Most Recent Events

    • 04 Dec 2008 Additional trial identifier TMAC A051 reported by ClinicalTrials.gov.
    • 14 May 2008 Status changed from in progress to discontinued.
    • 28 Mar 2008 Status changed from recruiting to in progress as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top